CASI Pharma (CASI) Misses Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. META
10. TLT

Go back to CASI Pharma (CASI) Misses Q4 EPS by 2c

CASI Pharmaceuticals Reports 2015 Fourth Quarter And Full Year Financial Results

March 28, 2016 7:00 AM EDT

ROCKVILLE, Md., March 28, 2016 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, today reported financial results for the three and 12 months ended December 31, 2015. 

The Company reported a net loss of ($1.7 million), or ($0.05) per share, for the three months ended December 31, 2015.  This compares with a net loss of ($1.6... More